New research shows pre-existing diabetes in pregnancy greatly increases the risk of death of the fetus or infant child

November 27, 2013

New research shows that pre-existing diabetes in pregnant women greatly increases the risk of death of their unborn fetus by around four-and-a-half times compared with pregnant women without diabetes, and also almost doubles the risk of death of infants after birth. The research, published in Diabetologia (the journal of the European Association for the Study of Diabetes), is by Dr Ruth Bell and Peter Tennant, Newcastle University, UK, and colleagues from Newcastle University, and the South Tees NHS Trust, UK and Public Health England.

While previous research has investigated links between pre-existing diabetes in mothers and deaths of unborn fetuses and young children, it has not previously excluded congenital anomalies from causes of death. In this new research, the authors used unique sources of data from several long-standing population-based registers in the north of England to investigate the association between pre-existing diabetes and the risks of fetal and in offspring without congenital anomalies.

All normally formed singleton offspring of with pre-existing diabetes (1,206 with and 342 with type 2 diabetes) in the North of England during 1996-2008 were identified from the Northern Diabetes in Pregnancy Survey. The relative risk of fetal death (i.e. death of a fetus at or after 20 weeks' gestation 2) and infant death (i.e. death during the first year of life) were estimated by comparison with population data from the Northern Perinatal Morbidity and Mortality Survey. Predictors of fetal and infant death in women with pre-existing diabetes were examined.

The researchers found that women with pre-existing diabetes were 4.56 times more likely to have their unborn fetus die compared with women without diabetes, while their infants were 1.86 times more likely to die. There was no difference in the risk of fetal and/or infant death in women with type 1 diabetes compared with type 2. Women with glycated haemoglobin (a standard measure of ) above 6.6%, those with pre-pregnancy retinopathy (a complication of diabetes) and a lack of folic acid supplementation were all found to be at higher risk of experiencing a fetal or infant death.

The prevalence of fetal death was 3% in women with pre-existing diabetes, and the prevalence of infant death was 0.7%, compared with 0.7% and 0.4% in women without the condition. The researchers found no evidence that the increased risk of fetal and infant death associated with pre-existing diabetes had decreased over time, nor that the relative risk of stillbirth varied by gestational age.

The average glycated haemoglobin level in the studied was 7.8%. England's National institute for Health and Care Excellence (NICE), has set a target of 6.1% for women, while the American Diabetes Association target is 7%. 'If the women in the study had all achieved either the ADA target or NICE target, the authors estimate the prevalence of and infant death would have been around 40% lower.

The authors commented: "It's disappointing to see so little improvement because, with the right care, most women with diabetes can - and will - have a healthy baby. Stillbirths and infant deaths are thankfully not common, but they could be even less common if all women with diabetes can be helped to achieve the best possible control of their blood glucose levels.

"We already know that folic acid reduces the risk of certain congenital anomalies, such as spina bifida or cleft lip, which is why women with diabetes are advised to take high dose supplements of 5 milligrams daily. These are available on prescription and should be taken for at least 3 months before conceiving. Our results suggest this simple action may also help to reduce the risk of stillbirth or infant death even in babies without these conditions."

They add: "If you are planning a pregnancy, and your blood glucose levels are high, then any reduction -even a small one - is likely to be good for your baby. Secondly, seek advice as early as possible from your diabetes team. They can help you keep your glucose at safe levels, as neither high nor repeated episodes of severe hypoglycaemia are good for you or your baby."

Explore further: Experts recommend universal diabetes testing for pregnant women at first prenatal visit

Related Stories

Experts recommend universal diabetes testing for pregnant women at first prenatal visit

November 5, 2013
The Endocrine Society today issued a Clinical Practice Guideline (CPG) to help health care professionals provide the best care to pregnant women who have diabetes.

Pre-pregnancy diabetes increases risk of MRSA among new mothers

July 1, 2013
Pregnant women with diabetes are more than three times as likely as mothers without diabetes to become infected with methicillin-resistant Staphylococcus aureus (MRSA) before hospital discharge, according to a study in the ...

Obesity among risk factors for delayed lactation in women with gestational diabetes

November 11, 2013
Pre-pregnancy obesity and older maternal age are among the risk factors for delayed lactation for women with gestational diabetes mellitus, according to a Kaiser Permanente study in The American Journal of Clinical Nutrition.

Pre-pregnancy hormone testing may indicate gestational diabetes risk

August 29, 2013
Overweight women with low levels of the hormone adiponectin prior to pregnancy are nearly seven times more likely to develop gestational diabetes, according to a Kaiser Permanente study published today in the journal Diabetes ...

Younger women with type 2 diabetes face higher risk of heart disease

September 12, 2013
Type 2 diabetes independently increases the risk of heart disease in premenopausal women, according to a study presented at the American Heart AssociationHigh Blood Pressure Research Scientific Sessions 2013.

Recommended for you

Diabetes pill might replace injection to control blood sugar

October 17, 2017
(HealthDay)— An injectable class of diabetes medication—called glucagon-like peptide-1 or GLP-1—might one day be available in pill form, research suggests.

Skimping on sleep may contribute to gestational diabetes

October 17, 2017
The amount of time spent sleeping in the United States has dropped significantly in the past twenty years with almost a quarter of women and 16 percent of men experiencing insufficient sleep. Now, a new study has found that ...

Artificial pancreas performs well in clinical trial

October 16, 2017
During more than 60,000 hours of combined use of a novel artificial pancreas system, participants in a 12-week, multi-site clinical trial showed significant improvements in two key measures of well-being in people living ...

Omega-6 fats may help prevent type 2 diabetes

October 11, 2017
The risk of developing type 2 diabetes could be significantly reduced by eating a diet rich in omega-6 polyunsaturated fats, a new study suggests.

Where there's type 1 diabetes, celiac disease may follow

October 10, 2017
(HealthDay)—Parents of young children with type 1 diabetes need to be on the lookout for symptoms of another autoimmune condition—celiac disease, new research suggests.

Type 1 diabetes and the microbiota—MAIT cells as biomarkers and new therapeutic targets

October 10, 2017
Together with colleagues from AP-HP Necker–Enfants Malades Hospital in Paris, scientists from the Cochin Institute (CNRS / INSERM / Paris Descartes University) have discovered that the onset of type 1 diabetes is preceded ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.